J&J disinvest ASP business to Fortive Corporation for $2.8 billion
Posted on03 Apr 2019
Comments0
Johnson & Johnson announced that it has completed the divestiture of its advanced sterilization products (ASP) business, a division of Ethicon, Inc.,... Read More
Ethicon receives FDA approval for surgicel powder absorbable hemostat
Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. Primary methods of hemostasis alone may be ineffective or... Read More